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Endocrinology & Metabolism International Journal

A Case of Amlodipine Overdose: Role of High Dose
Insulin Therapy
Case Report

Abstract
Introduction: High dose insulin (HDI) therapy, defined as > 0.5 units/kg/hour,
has been postulated to improve hemodynamics in both calcium channel blocker
(CCB) and beta-blocker overdose. Proposed benefits of HDI include coronary
and systemic vasodilation due to enhancement of nitric oxide synthase activity
leading to improved contractility and decreased systemic vascular resistance,
respectively. HDI also directly improves cardiac contractility by increasing
glucose uptake and improving calcium handling within cardiac cells. We present
a case of a patient with amlodipine overdose and her response to HDI therapy.
Case presentation: A 52 year old female presented with amlodipine overdose
after suicide attempt leading to shock. She received continuous intravenous
infusion of regular insulin at a rate of 2 units/kg/hour and epinephrine titrated
up to 80 mcg/hour to maintain mean arterial pressure above 65. After several
hours, there was concern for worsening hypokalemia so insulin was suspended.
Patient subsequently became more hypotensive, requiring further uptitration of
epinephrine. When continuous insulin was later restarted, there was an observed
immediate improvement in blood pressure. Patient was eventually weaned off of
vasopressors, followed by insulin, by day 3. She was downgraded from the ICU
on day 5.

Conclusion: In patients with CCB overdose, initial management should include
fluid resuscitation, calcium supplementation, and early consideration of
vasopressors and HDI therapy. Although there are currently no controlled human
studies to evaluate the benefits of HDI therapy, this case revealed worsening
hypotension upon cessation of therapy followed by rapid improvement in blood
pressure when restarting insulin. Based on this observation, HDI therapy may
have a prominent role in management of CCB overdose.
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Introduction

Calcium channel blockers (CCB) are a leading cause of
mortality from drug overdose among cardiovascular medicine [1].
CCBs are commonly used for treating hypertension, angina, and
arrhythmias. However in an overdose, this can lead to cardiogenic
shock that is difficult to treat with vasopressors alone and is
especially problematic for long-acting agents such as amlodipine.
Insulin is widely used in treatment of diabetes mellitus,
hypertriglyceridemia, and hyperkalemia. High dose insulin
(HDI) therapy, defined as >0.5 units/kg/hr, has been postulated
to improve hemodynamics in CCB poisonings given its positive
inotropic and vasodilatory effects at the capillary beds leading to
decreased vascular resistance and improved cardiac output.

Case Presentation

A 52 year old female with a history of hypertension, depression
and previous suicide attempts was brought into the emergency
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department (ED) with acute encephalopathy. EMS found the
patient on her bed with snoring respirations and was very difficult
to arouse. There was a suicide note by the patient stating that she
took amlodipine. There were no family members or housemates
nearby, so the onset of ingestion could not be determined.

Upon arrival in the ED, the patient was found to be hypotensive
with blood pressure 68/53. The patient weighed 65.6 kg. On
exam, she appeared stuporous. There were significant snoring
respirations but no other abnormal lung sounds were appreciated
bilaterally. Heart auscultation was unremarkable. There were no
signs of acute injury on abdominal exam. Cranial nerves 2-12
were grossly intact. She opens her eyes to her name and has
spontaneous movements in all extremities but she does not
follow commands. Initial laboratory studies, as shown in Table 1,
revealed hypokalemia and mildly decreased CO2. The corrected
calcium was normal, measured at 8.9. Urinalysis was not
suggestive of a UTI and otherwise unremarkable. Her chest x-ray
and computed tomography of the head on admission revealed no
acute pathology.
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Table 1: Laboratory studies during hospital course.
Time

Day 1

Day 2

Day 3

Day 4

Sodium

138

136

133

134

Chloride

108

109

107

104

Anion Gap

11

15

7

4

Potassium
CO2

3.0
19

2.9
12

4.3
19

3.5
26

Glucose

139

390

113

72

Creatinine

1.02

1.81

0.73

0.503

Albumin

3.2

2.8

2.0

1.7

BUN

Calcium

Total Bilirubin

Alkaline Phosphate
Aspartate
Aminotransferase
Alanine
Aminotransferase

22

8.3
1.0

7.5

18

7.0

9

6.8

57
12
23

Lactic Acid

1.5

Troponin-I

<0.015

Creatine Kinase

26

86

7.4

4.1

1.8

Patient was given 3 liter boluses of normal saline and 4 gm
of calcium gluconate without adequate response to the blood
pressure. She was started on intravenous regular insulin at a rate
of 150 units per hour with dextrose 10% in water at rate of 50 ml/
hr. Epinephrine was administrated at the same time and titrated
up to 80 mcg per minute to maintain mean arterial pressure above
65. Potassium chloride supplements were also administered to
prevent hypokalemia while on insulin infusion.

Approximately eight hours after admission (day 2), the next
renal panel revealed a potassium level of 2.9. Given concern for
continued worsening of hypokalemia, the insulin infusion was
suspended. Two hours later, mean arterial pressure dropped
significantly requiring uptitration of epinephrine up to 90 mcg/
minute. Patient was subsequently noted to be more somnolent,
and she was intubated for airway protection. 3 hours after
suspending insulin, it was then restarted at 150 units per hour
with dextrose 10% at 50 ml/hr. Almost immediately afterwards,
there was an observed improvement in mean arterial pressure.
Over the next 24 hours, potassium was supplemented
approximately 40-50 mEq every 4 hours along with magnesium
and phosphorus. Potassium levels were well maintained and
never went below 3.2. The most notable adverse effect was
hypoglycemia but responding well to dextrose 50% pushes and
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increased dextrose 10% continuous infusion rate up to 140 ml
per hour. The patient continued to show improvement in blood
pressure. By day 4, insulin and epinephrine were weaned off
completely and the patient was downgraded from the ICU on day
5.

Discussion

Two main classes of CCBs exist on the market: dihydropyridines
and non-dihydropyridines (Table 2). Non-dihydropyridine CCBs
have a strong affinity for the myocardium, including cardiac
myocytes and pacemaker cells. They decrease myocardial
contractility, decreased heart rate, and decreased conductivity
making them useful for treating angina or cardiac arrhythmias.
Amlodipine is a type of long-acting dihydropyridine CCB. At
therapeutic doses, this class of CCBs act predominantly on L-type
calcium channels on vascular smooth muscle cells with little effect
on the myocardium [2]. Amlodipine is commonly prescribed for
hypertension given its favorable adverse effect profile compared
to other antihypertensive agents. In severe dihydropyridine CCB
overdose, there is less selectivity for peripheral vascular effects
and cardiac adverse effects may be seen leading to refractory
cardiogenic shock. CCB overdose may also inhibit L-type channels
of pancreatic islet cells which decreases insulin release and can
cause hyperglycemia [3]. Other non-cardiovascular adverse
effects following CCB overdose include confusion, agitation,
altered mentation, and seizures likely due to decreased cerebral
perfusion from hypotension [4].
Table 2: Common CCBs used in the US.
Dihydropyridine CCB

Non-dihydropyridine CCB

Amlodipine
Clevidipine
Nifedipine
Nicardipine
Nimodipine
Nimodipine

Verapamil
Diltiazem

Numerous animal studies have shown beneficial effects of
HDI therapy. In canines, HDI therapy was compared to other
conventional therapies and showed significant improvement in
myocardial contractility [5]. Canines induced with propranolol
with subsequent myocardial depression and later treated with
HDI showed reversal of myocardial depression [6]. In swine
models, HDI and epinephrine therapy exhibited similar increases
in myocardial contractility but epinephrine effects appeared to be
temporary, lasting up to 90 minutes despite continuous infusion
up to a maximum dose of 50 mcg/kg/min. In contrast, HDI therapy
maintained myocardial contractility significantly longer leading to
marked increase in survival among the HDI group [7]. Nifedipine
overdose in pigs treated with HDI versus combination HDI and
vasopressors show no significance in survivability, cardiac index,
and mean arterial pressure [8].
Many mechanisms have been proposed for the positive
effects of HDI therapy. In contrast to vasopressors, HDI acts as
a vasodilator in systemic, coronary, and pulmonary vasculature
due to enhancement of endothelial nitric oxide synthase activity.
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Insulin enhances microvascular perfusion by increasing total
blood flow to the capillary beds in the setting of cardiogenic shock.
This effect decreases vascular resistance and enhances cardiac
output [9]. During states of significant stress, the myocardium
primarily uses glucose as the preferred energy substances in
contrast to fatty acids under non-stressed states. Insulin increases
intracellular transport of glucose in cardiac muscle, and this is
believed to contribute to increased myocardial contractility [10].
This effect has also been studied in explanted human myocardium
and show increased inotropic function when exposed to insulin
[11] (Image 1).

Image 1: Mechanism of action of HDI therapy.

Many case reports have implicated beneficial effects of HDI
therapy in calcium channel blocker and beta-blocker poisoning.
There is no recommended standard dosing and rate of insulin
administration but most clinicians administer an initial insulin
bolus 1 unit/kg followed by a 0.5-2 units/kg/hour continuous
infusion. Benefits have been reported in as little as 0.015 units/
kg/hour up to 22 units/kg/hour. HDI therapy is typically started
early during cardiogenic shock and at the same time as starting
vasopressors [9,12,13]. Once the patient is hemodynamically
stable, vasopressors are weaned off first followed by HDI therapy.
Cases in the literature report worse outcome and decreased
survival when HDI therapy is not started early likely because of
the temporarily benefits from vasopressor alone and the lack of
positive inotropic effects of insulin [9].

The most common adverse effect of HDI therapy is
hypoglycemia. Administration of 5-10% dextrose continuous
infusion and high dose dextrose pushes is given concomitantly
with HDI therapy to maintain euglycemia. Consideration of glucose
infusions greater than 10% through a central venous catheter
may be warranted if there is concern for fluid overload. Frequent
glucose checks initially every 10 minutes is recommended until
glucose levels stabilize. Dextrose supplementation may need
to be continued post HDI therapy due to persistent insulin
concentrations. Hypokalemia is another concern of HDI therapy,
as is the case with insulin infusions during treatment of diabetic
ketoacidosis or hyperglycemic hyperosmolar nonketotic state.
Fortunately, severe hypokalemia as defined by the presence of
EKG changes is rarely seen with HDI therapy when supplemented
with continuous or bolus potassium replacements. This is likely
due to the shifting of potassium cations into the cell and not
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total body depletion of potassium. Potassium, magnesium, and
phosphorus levels also should be checked frequently until levels
have stabilized.

Currently, there are no clinical trials to compare the efficacy
of HDI therapy alone versus vasopressor therapy alone or
vasopressor and HDI therapy. Levine et al. evaluated 45 patients
overdosed on CCBs and showed good survival outcome on
vasopressor therapy alone [14]. However, early initiation of HDI
has been implicated in many controlled animal trials and clinical
case reports as beneficial therapy for CCB overdose. We presented
a case of a patient who overdosed on amlodipine. Due to concerns
for worsening hypokalemia, insulin therapy was held and
subsequently there was an observed worsening of hemodynamic
status. Upon re-initiation of insulin there was an immediate
improvement in mean arterial blood pressures suggesting that
HDI therapy may play a significant role in CCB overdose.

Initial CCB overdose management should include IV fluid
resuscitation, consideration of intubation for airway protection
if necessary, and laboratory/imaging studies to rule out other
contributory diagnoses including infection and polysubstance
use. Gastric lavage or activated charcoal may be considered if
patients present less than 1 hour post-ingestion. IV calcium is
also recommended in early management for improvement in
contractility and blood pressure because it is readily available
and carries little risk [15-18]. Vasopressor and HDI therapy
should be considered early to maintain mean arterial pressures
with frequent glucose and electrolyte monitoring. While our
patient experienced hypoglycemia and hypokalemia, both issues
were well managed with continuous dextrose infusions and
conventional potassium replacement protocols. Based on this
case and other case studies in the literature, HDI appears to be a
promising treatment for CCB poisoning.
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